Dear Customer,
We are no longer producing our TEBS Eye Formula for Macula Support that hadBeta-Carotene.
The results of the AREDS 2 (Second Age Related Eye Disease Study) reported in MAY 2013, showed that substituting Lutein for Beta-carotene in the original AREDS formula was equally effective in slowing the progression of macular degeneration and safer for those who smoke. We have had our TEBS Eye Formula for Macular Support- Smokers Formula (no Beta- carotene; 8mg Lutein) for the last 10 years. We named it “Smokers” just to differentiate it from the product with beta- carotene. Eye Doctors have been recommending our “Smokers” formula to both their non-smoking and smoking patients for years. For simplicity reasons only, we have decided to have only one AREDS based product and eliminate the original product that contained beta-carotene as well as the “Smokers” label. We have our new label AREDS 2 product TEBS Macula Support 2 available now. The new formula as recommended by the AREDS 2 report is essentially our “Smokers” formula with an additional 2mg of Lutein for a total of 10mg in the daily dose.


.Age-Related Eye Disease Study Results can be found at: http://www.nei.nih.gov/amd/


Antioxidant Supplements have shown in recent clinical studies to be effective in slowing down the progression of cataracts and macular degeneration. Antioxidants are also important in supporting the circulatory system, immune system, and many other functions of the body. Antioxidants include: Vitamins A, C, E, bilberry, ginkgo biloba, grape seed extract, zinc, selenium and others. Consuming a diet rich in leafy green vegetables will supply a lot of Vitamin A, which has been found to be helpful in reducing the progression of age-related macular degeneration in some patients.

Clinical studies have shown the possible reduction in cataract formation with the use if vitamins C and E. In the May 1998 edition of OPHTHALMOLOGY, a study of 764 patients by Dr. Leske concluded that in regular users of multivitamin supplements, the risk of nuclear cataract was reduced by one third; in regular users of Vitamin E supplements the risk was reduced by approximately one half.

Studies of patients with age-related macular degeneration, a progressive retinal disorder that can affect one or both eyes and result in the loss of central vision, have shown the decreased progression of this disease with the increased dietary intake of carotenoids (Vitamin A family) and other antioxidants. In the November 9, 1994 edition of Journal of the American Medical Association, Dr. Seddon found that a higher intake of carotenoids was associated with a lower risk of age-related macular degeneration. The study found that people who consume carotenoids had a statistically significant 43 percent lower risk for age-related macular degeneration compared to those who consumed the lowest. LUTEIN was the carotenoid most strongly associated with the reduced risk of age-related macular degeneration.

Since individual diets may vary on the amount of fruits and leafy, green vegetables, taking a quality multivitamin may be helpful in obtaining the amount of vitamins that reduce the progression of cataracts and age-related macular degeneration. For those who choose to take supplements, TEBS provides optimal nutritional support fir the eyes and total body. With TEBS you should not have to take any other vitamins because it is a complete multivitamin and mineral supplement with additional antioxidants: Lutein, bilberry, ginkgo biloba, grape seed extract, and eyebright to name a few. TEBS has considerable more antioxidants and a lot more of them at higher amounts that many of the eye vitamins on the market.

To achieve the potential benefit, vitamins should be taken regular on z daily basis. The recommended dose is two to six tablets of TEBS daily with food. The maximum dose is six tablets per day. TEBS is formulated so that the dose can be adjusted for age and eye condition. The higher doses of three to six tablets daily are for older individuals with macular degeneration.
 

Age-Related Eye Disease Study Results